Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
261,899,509
-
Share change
-
-3,388,771
-
Total reported value
-
$13,992,979,930
-
Put/Call ratio
-
65%
-
Price per share
-
$53.43
-
Number of holders
-
704
-
Value change
-
-$180,904,383
-
Number of buys
-
342
-
Number of sells
-
240
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q1 2014
As of 31 Mar 2014,
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by
704 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
261,899,509 shares.
The largest 10 holders included
Dodge & Cox, ROYAL BANK OF CANADA, Fisher Asset Management, LLC, State Street Corp, BANK OF AMERICA CORP /DE/, PRIMECAP MANAGEMENT CO/CA/, PRICE T ROWE ASSOCIATES INC /MD/, WELLS FARGO & COMPANY/MN, RENAISSANCE TECHNOLOGIES LLC, and Bank of New York Mellon Corp.
This page lists
704
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.